Costs of Respiratory Syncytial Virus Hospitalizations in Colombia

Jefferson Antonio Buendía () and Diana Guerrero Patiño ()
Additional contact information
Jefferson Antonio Buendía: Universidad de Antioquia
Diana Guerrero Patiño: Hospital Infantil Concejo de Medellín

PharmacoEconomics - Open, 2021, vol. 5, issue 1, No 8, 76 pages

Abstract: Abstract Background Several clinical practice guidelines exist for the management of respiratory syncytial virus (RSV) infection, but the use and overuse of medications and medical tests with insufficient evidence of effectiveness remains substantial. Objective This study aimed to evaluate the medical costs associated with bronchiolitis hospitalizations caused by RSV infection among infants aged

Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-020-00218-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:5:y:2021:i:1:d:10.1007_s41669-020-00218-7

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-020-00218-7

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().